Clinical Trials
3
Active:1
Completed:2
Trial Phases
2 Phases
Phase 2:2
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 3
1 (33.3%)A Study to Evaluate the Efficacy, Immunogenicity and Safety of an EV71 Vaccine in Healthy Infants and Children
Phase 3
Active, not recruiting
- Conditions
- Enterovirus Infections
- First Posted Date
- 2021-10-29
- Last Posted Date
- 2024-08-28
- Lead Sponsor
- Enimmune Corporation
- Target Recruit Count
- 3982
- Registration Number
- NCT05099029
- Locations
- 🇨🇳
Changhua Christian Hospital, Changhua, Taiwan
🇨🇳National Taiwan University Hospital HsinChu Branch, Hsinchu, Taiwan
🇨🇳China Medical University Hospital, Taichung, Taiwan
A Study to Evaluate the Immunogenicity and Safety of EV71 Vaccine in Pediatric Subjects
Phase 2
Completed
- Conditions
- Enterovirus Infections
- First Posted Date
- 2017-08-31
- Last Posted Date
- 2021-10-26
- Lead Sponsor
- Enimmune Corporation
- Target Recruit Count
- 140
- Registration Number
- NCT03268083
- Locations
- 🇨🇳
China Medical University Hospital, Taichung, Taiwan
🇨🇳National Taiwan University Hospital, Taipei, Taiwan
🇨🇳Taipei Veterans General Hospital, Taipei, Taiwan
A Study to Evaluate the Safety and Immunogenicity of EV71 Vaccine in Pediatric Subjects Aged 3 to 6 Years and 6 to 35 Months Old
Phase 2
Completed
- Conditions
- Enterovirus Infections
- First Posted Date
- 2016-05-19
- Last Posted Date
- 2016-11-30
- Lead Sponsor
- Enimmune Corporation
- Target Recruit Count
- 122
- Registration Number
- NCT02777411
- Locations
- 🇨🇳
China Medical University Hospital, Taichung, Taiwan
🇨🇳National Taiwan University Hospital, Taipei, Taiwan
🇨🇳Taipei Veterans General Hospital, Taipei, Taiwan
News
No news found